Vilazodone (Viibryd) Dosing, Contraindications, and Safety
Vilazodone should be initiated at 10 mg once daily with food for 7 days, then increased to 20 mg daily, with a target dose of 20-40 mg once daily—always taken with food to ensure adequate absorption. 1
Dosing Regimen
Standard Titration:
- Days 1-7: 10 mg once daily with food
- Day 8 onward: 20 mg once daily with food
- Optional increase: Up to 40 mg once daily after minimum 7 days at 20 mg dose 1
Critical requirement: Vilazodone must be taken with food—this is not optional. Without food, plasma concentrations are inadequate and the medication will not work effectively 1, 2.
Dose Adjustments with Drug Interactions
With strong CYP3A4 inhibitors (itraconazole, clarithromycin, voriconazole):
- Maximum dose: 20 mg once daily
- Resume original dose when inhibitor discontinued 1
With strong CYP3A4 inducers (carbamazepine, phenytoin, rifampin) used >14 days:
- Increase vilazodone up to 2-fold (maximum 80 mg daily) over 1-2 weeks
- Taper back to original dose over 1-2 weeks when inducer discontinued 1
Discontinuation Protocol
Never stop vilazodone abruptly. Gradual tapering prevents discontinuation symptoms 1:
- From 40 mg daily: Reduce to 20 mg for 4 days, then 10 mg for 3 days
- From 20 mg daily: Reduce to 10 mg for 7 days
Contraindications
Absolute contraindication: Monoamine oxidase inhibitors (MAOIs) 1
- Allow 14 days between stopping MAOI and starting vilazodone
- Allow 14 days between stopping vilazodone and starting MAOI
This contraindication exists because vilazodone combined with MAOIs can precipitate serotonin syndrome or hypertensive crisis 3.
Safety Precautions
Mandatory Screening
Screen all patients for bipolar disorder before initiating vilazodone 1. Antidepressants can precipitate manic episodes in undiagnosed bipolar disorder.
Common Adverse Effects
The most frequent side effects requiring patient counseling 4, 5:
- Diarrhea (31% vs 11% placebo)
- Nausea (26% vs 6% placebo)
- Vomiting (particularly at 40 mg dose)
- Insomnia
- Headache
These gastrointestinal effects are why dose titration over 2 weeks is essential—starting at full dose causes intolerable GI symptoms 2, 6.
Serious Safety Concerns
Serotonin syndrome risk: Unlike typical SSRIs, vilazodone can cause serotonin syndrome even in single-substance ingestions 7. This is particularly dangerous in:
- Pediatric exposures (children develop seizures and serotonin syndrome from as little as 10 mg)
- Combination with other serotonergic drugs
- Overdose situations requiring ICU admission and intubation 7
Sexual dysfunction: While marketed as having fewer sexual side effects than SSRIs due to its 5-HT1A partial agonist activity, clinical trial data show treatment-related sexual effects similar to placebo 4. Real-world experience may differ.
Weight effects: No significant difference from placebo in clinical trials 4.
Time to Efficacy
Patients should expect improvement within 1-2 weeks, with full therapeutic effect at 4-8 weeks 8, 6, 9. This is consistent with other antidepressants despite theoretical advantages from its dual mechanism.
Clinical Pitfalls
Food requirement is non-negotiable: The most common prescribing error is failing to emphasize that vilazodone must be taken with food. Without food, bioavailability drops significantly and treatment fails 1, 2.
Pediatric exposures are dangerous: Even minimal doses (10 mg) can cause major toxicity in children, including seizures and serotonin syndrome requiring ICU care 7. This medication should be stored securely away from children.
No proven advantages over SSRIs: Despite its unique mechanism combining SSRI effects with 5-HT1A partial agonism, head-to-head trials demonstrating superiority to standard SSRIs are lacking 2, 9. Its higher cost and similar adverse effect profile limit its role as a first-line agent.